Diagnostic value of the ultraviolet biological dose in detecting autonomic changes in patients with diffuse sclerosis
Starostenko, L.I.
Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 36(5): 421-422
1971
ISSN/ISBN: 0042-8787 PMID: 5156843 Document Number: 31698
Document emailed within 1 workday
Related Documents
Di Paolo, M.; Gigante, A.; Liberatori, M.; Sardo, L.; Marinelli, P.; Rossetti, M.; Palange, P.; Tubani, L.; Rosato, E. 2018: Effects of autonomic dysfunction on exercise tolerance in systemic sclerosis patients without clinical and instrumental evidence of cardiac and pulmonary involvement Clinical and Experimental Rheumatology 36 Suppl 113(4): 61-67Tang, A.; Udey, M.C. 1991: Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation. Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells Journal of Immunology 146(10): 3347-3355
Baranov, V.G.; Potin, V.V.; Stepanov, G.S.; Shliakhtina, L.G. 1970: Characteristics of the biological effect of the thyrotropic activity of the blood of diffuse toxic goiter patients Problemy Endokrinologii 16(6): 27-33
Nesterova, E.S.; Mangasarova, I.K.; Bariakh, E.A.; Gubkin, A.V.; Tolstykh, T.N.; Lukina, A.I.; Kovrigina, A.M.; Domracheva, E.V.; Chernova, N.G.; Mar'in, D.S.; Zvonkov, E.E.; Gemdzhian, É G.; Kravchenko, S.K. 2014: Experience with high-dose chemotherapy in patients with testicular diffuse large B-cell lymphoma Terapevticheskii Arkhiv 86(7): 59-67
Antsupova, A.S.; Troitskaia, M.V.; Zvereva, K.V.; Vostokova, A.A. 1980: Diagnostic value of detecting neutralizing antibodies to Coxsackie B enteroviruses in patients with infectious-allergic myocarditis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 40-42
Genovese, M.C.; Chakravarty, E.F.; Boyle, D.L.; Tutuncu, Z.; Thorburn, C.M.; Halilhodzic, M.; Kroll, S.; Baughman, J.; Stewart, S.; Kavanaugh, A. 2005: A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis Journal of Rheumatology 32(12): 2345-2350
Zagaladze, E.D.; Ginevskaia, V.A.; Shirman, G.A.; Eremeeva, T.P.; Kazantseva, V.A.; Sakvarelidze, L.A.; Drozdov, S.G. 1989: Assessment of diagnostic prospects for a method of immunoenzyme analysis during mass testing of feces of patients for the purpose of detecting rotavirus antigens Voprosy Virusologii 34(4): 503-505
Seres, E.; Bencsik, K.; Rajda, C.; Vécsei, L. 1998: Diagnostic studies of cerebrospinal fluid in patients with multiple sclerosis Orvosi Hetilap 139(32): 1905-1908
Silver, R.M.; Warrick, J.H.; Kinsella, M.B.; Staudt, L.S.; Baumann, M.H.; Strange, C. 1993: Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease Journal of Rheumatology 20(5): 838-844
Jóźwiak, S.; Michałowicz, R. 1991: Changes in kidneys and liver of patients with tuberous sclerosis--diagnostic and therapeutic aspects Polski Tygodnik Lekarski 46(40-42): 787-789
Fukaura, H. 2015: Diagnostic criteria to patients with multiple sclerosis and clinically isolated syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 7): 173-180
Bergamaschi, R.; Versino, M.; Raiola, E.; Citterio, A.; Cosi, V. 1993: High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. one year follow-up Acta Neurologica 15(1): 33-43
Carter, J.L.; Hafler, D.A.; Dawson, D.M.; Orav, J.; Weiner, H.L. 1988: Immunosuppression with high-dose I.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients Neurology 38(7 Suppl 2: 9-14
Baranova, N.S.; Spirin, N.N.; Fadeeva, O.A.; Shipova, E.G.; Stepanov, I.O. 2012: Lyme disease in patients with multiple sclerosis: clinical, diagnostic and therapeutic features Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(2 Part 2): 64-68
Sierakowska, M.; Sierakowski, S.ła.; Doroszkiewicz, H.; Lewko, J.; Jankowiak, B.; Kowalczuk, K.; Van Damme-Ostapowicz, K.; Krajewska-Kułak, E. 2011: Symptoms from the internal organs of patients with systemic sclerosis in the light of selected diagnostic tests Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 30(176): 116-120
Niibe, Y.; Hayakawa, K.; Kanai, T.; Tsunoda, S.; Arai, M.; Jobo, T.; Kuramoto, H.; Unno, N. 2006: Optimal dose for stage IIIB adenocarcinoma of the uterine cervix on the basis of biological effective dose European Journal of Gynaecological Oncology 27(1): 47-49
Papajik, T.; Raida, L.; Faber, E.; Vondrakova, J.; Prochazka, V.; Kubova, Z.; Skoumalova, I.; Jarosova, M.; M, L.K.; Paucek, B.; Myslivecek, M.; Neoral, C.; Oral, I.; Jarkovsky, J.; Dusek, L.; Indrak, K. 2008: High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission Neoplasma 55(3): 215-221
Li, W-hong.; Xu, W-xian.; Li, Z-ping.; Li, C-ping.; Wang, X-yu.; He, L-yun.; Zhao, W.; Feng, X-heng.; Gao, W. 2013: Impact of uncontrolled blood pressure on diagnostic accuracy of coronary flow reserve for detecting significant coronary stenosis in hypertensive patients Chinese Medical Journal 126(5): 839-844
Kurzrock, R.; Rosenblum, M.G.; Sherwin, S.A.; Rios, A.; Talpaz, M.; Quesada, J.R.; Gutterman, J.U. 1985: Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients Cancer Research 45(6): 2866-2872
Grzesik, J.; Marzec, S. 1985: Biological criteria of the hygienic evaluation of ultraviolet radiation Polski Tygodnik Lekarski 40(37): 1048-1053